Q3 Medical Group is a growth stage commercial company which is leading innovations in biodegradable implants and micro invasive technology for the Interventional Radiology, Gastro Intestinal, and open Surgical procedures which will change the face of healthcare, helping us achieve our mission of providing better clinical outcomes and reducing the overall cost of care.
Q3 Medical is based in Dublin, Ireland. Q3’s wholly owned subsidiaries, QualiMed and Amg International are focused on the development, approval, manufacturing, and sales of our products. Our manufacturing site is currently located in Winsen (Luhe) in Germany with future growth plans to have a secondary site in China.
We have challenged ourselves to become a global leader in creating, manufacturing and selling innovative medical technology that aligns with our ultimate vision “CREATING VALUE BY HELPING PEOPLE”.
Our Products:
• ARCHIMEDES- Biodegradable Biliary and Pancreatic Stent
• UNITY-B Endo/Perc- Biodegradable Balloon Expandable Biliary Stent System
• Micro Invasive Technology
• Peripheral Vascular
Our Growth Plans:
• 2nd Manufacturing Site- QSAN in China
• FDA Approval- Q3 USA
• Ultimate Goal of IPO
Q3 Medical Group- www.q3medical.com |
Qualimed- www.qualimed.de |
AMG International- www.amggastro.com |
-
Industry
-
Medical Equipment Manufacturing
-
Company size
-
51-200 employees
-
Headquarters
-
Dublin, County Dublin
-
Type
-
Privately Held
-
Founded
-
2013
-
Specialties
-
Biodegradable, Biliary Stents, Pancreatic Stents, Interventional Cardiology, Peripheral Vascular, Gastroenterology, and Interventional Radiology